Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

Standard

Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5. / Ford, C. E.; Tuomela, J.; Hedditch, E. L.; Axelsson, Lena; Liu, Qing; Ward, R. L.; Harkonen, P.; Andersson, Tommy.

I: EJC Supplements, Vol. 8, Nr. 5, 2010, s. 43.

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

Harvard

Ford, CE, Tuomela, J, Hedditch, EL, Axelsson, L, Liu, Q, Ward, RL, Harkonen, P & Andersson, T 2010, 'Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5', EJC Supplements, vol. 8, nr. 5, s. 43. https://doi.org/10.1016/S1359-6349(10)70852-1

APA

Ford, C. E., Tuomela, J., Hedditch, E. L., Axelsson, L., Liu, Q., Ward, R. L., Harkonen, P., & Andersson, T. (2010). Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5. EJC Supplements, 8(5), 43. https://doi.org/10.1016/S1359-6349(10)70852-1

CBE

Ford CE, Tuomela J, Hedditch EL, Axelsson L, Liu Q, Ward RL, Harkonen P, Andersson T. 2010. Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5. EJC Supplements. 8(5):43. https://doi.org/10.1016/S1359-6349(10)70852-1

MLA

Ford, C. E. et al. "Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5". EJC Supplements. 2010, 8(5). 43. https://doi.org/10.1016/S1359-6349(10)70852-1

Vancouver

Ford CE, Tuomela J, Hedditch EL, Axelsson L, Liu Q, Ward RL et al. Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5. EJC Supplements. 2010;8(5):43. https://doi.org/10.1016/S1359-6349(10)70852-1

Author

Ford, C. E. ; Tuomela, J. ; Hedditch, E. L. ; Axelsson, Lena ; Liu, Qing ; Ward, R. L. ; Harkonen, P. ; Andersson, Tommy. / Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5. I: EJC Supplements. 2010 ; Vol. 8, Nr. 5. s. 43.

RIS

TY - JOUR

T1 - Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5

AU - Ford, C. E.

AU - Tuomela, J.

AU - Hedditch, E. L.

AU - Axelsson, Lena

AU - Liu, Qing

AU - Ward, R. L.

AU - Harkonen, P.

AU - Andersson, Tommy

PY - 2010

Y1 - 2010

U2 - 10.1016/S1359-6349(10)70852-1

DO - 10.1016/S1359-6349(10)70852-1

M3 - Published meeting abstract

VL - 8

SP - 43

JO - European Journal of Cancer Supplements

JF - European Journal of Cancer Supplements

SN - 1359-6349

IS - 5

T2 - 21st Meeting of the European-Association-for-Cancer-Research

Y2 - 26 June 2010 through 29 June 2010

ER -